Patterns of Lymphoid Neoplasia in Peripheral Blood. Leon F. Baltrucki, M.D. Leon F. Baltrucki, M.D. Disclosure

Size: px
Start display at page:

Download "Patterns of Lymphoid Neoplasia in Peripheral Blood. Leon F. Baltrucki, M.D. Leon F. Baltrucki, M.D. Disclosure"

Transcription

1 Patterns of Lymphoid Neoplasia in Peripheral Blood Leon F. Baltrucki, M.D. Leon F. Baltrucki, M.D. Disclosure Dr Baltrucki has received an honorarium for his participation as a faculty presenter in this educational activity. 1

2 Patterns of Lymphoid Neoplasia in Peripheral Blood Leon F. Baltrucki, M.D. Leon F. Baltrucki, M.D. Lymphoid Neoplasia - Overview Broad Variety of Diseases Clinically Indolent > Life Threatening Many Rarely Encountered Disease Detection Requires Correlation of Analyzer Data and Blood Smear Findings, with Cumulative Hematological Data and Clinical Findings Flow Cytometry & FISH Cytogenetics Detection, Recognition of Disease Progression & Complications Based on Patterns Reflecting Natural Hx 2

3 Problems with Disease Recognition Laboratory Requirements Concerted Cooperative Effort High Degree of Expertise in Cytology Oversight Disease Features Diversity a clinical-biological spectrum Variation - different forms of same entity Similarity Overlapping Features with subtle differences Rarity many entities rarely encountered Evolution from low-grade neoplasia or chronic reactive conditions Patterns of Lymphoid Neoplasia in Peripheral Blood Quantitative Lymphocytosis Lymphopenia +/- Anemia +/- Thrombocytopenia +/- Neutropenia Monocytosis Neutrophilia Eosinophilia Qualitative Scatterplots Diff IMI WBC IP Messages Atypical Lympho? Abn Lympho/L_Blasts? Monocytosis Blasts? Immature Gran? Cytology 3

4 Patterns of Lymphocytosis Analyzer Features Scatterplots IP Messages Atypical Lympho? Abn Lympho/L_Blasts? Monocytosis Hematological Features Magnitude Anemia / Cytopenias Monocytosis Neutrophilia Eosinophilia Clinical Features Historical Features Duration Doubling Time Cytological Features Degree of Variation Nuclear Irregularity Prominent Nucleoli Diagnostic Algorithms CBC + Automated WBC diff Cell Counts + IP messages Blood Smear Findings Abnormal Cytology Chart Review Clinical Context + Cumulative CBC Data Flow Cytometry FISH / Genetic Testing Molecular / Cellular Diagnosis 4

5 Flow Cytometry Cell Surface Antigens FITC Monoclonal Abs Lambda- PE CD23- PE CD20- FITC CD5- FITC Mature B-Cell Leukemias Flow Cytometry MCL HCL LPL MZL FL PLL PCL SIg +/ CyIg +++ CD / CD CD /+ -/+ -/+ - FMC7 -/ CD / CD CD38 -/+ - -/ /

6 Fluorescence In Situ Hybridization 11q13 region CCND1 IGH - JH Fusion Signals CCND1 14q32 region IGH - JH Normal Genes INTERPRETATION: Positive for a CCND1/IGH rearrangement Mature B-Cell Neoplasms - Leukemias Chronic Lymphocytic Leukemia Mantle Cell Leukemia B-Cell Prolymphocytic Leukemia * Splenic Marginal Zone Lymphoma Hairy Cell Leukemia Lymphoplasmacytic Lymphoma Plasma Cell Myeloma Plasma Cell Leukemia * Follicular Lymphoma (Leukemic) Burkitt s Leukemia * 6

7 Mature B-Cell Neoplasms Cytology B-PLL HCL MCL LPL MZL FL BL - Cytology Early Stage/ Chronic Phase Small Cells Uniform Population High N/C ratio Round Nucleus Clumped/Cracked to Condensed Chromatin Inconspicuous Nucleolus Pale Basophilic Cytoplasm 7

8 -Population Assessment Typical Chronic Phase Atypical or Advanced Prolymphocyte Genetic Risk-Stratification in 13q del Tri 12q Normal 17p del 11q del 8

9 - Natural History MZL MCL LPL Early MCL B-PLL Middle Late Date Range: All Results from 01/04/97 to 03/10/07 Disease Progression Prolymphocytoid Transformation 9

10 DDx: Atypical or Progressive MCL B-PLL vs. MCL MCL 10

11 Mantle Cell Leukemia Hyper-mutation Features like ALL B-Prolymphocytic Leukemia Peripheral Blood, Bone Marrow & Spleen WBC > 100 K Prolymphocytes > 55% Marked Anemia & Thrombocytopenia Massive Splenomegaly Complex Cytogenetics B Symptoms Rapidly Progressive 11

12 Splenic Marginal Zone Lymphoma Lymphocytosis mild Low-Grade Cytology / Villous Projections +/PB, Bone Marrow & Spleen Involvement MZL +/- Hepatitis C +/+/ Monoclonal Paraprotein +/- ITP, AIHA HCL Rare Transformations to High-Grade NHL HCL Bone Marrow Classic Pattern Reticulin Fibrosis Hypoplastic Marrow Spindle-Cell Pattern CD20 12

13 Classic Hairy Cell Leukemia - Cytology Pancytopenia Pattern Neutropenia Moderate to Marked Thrombocytopenia mild to moderate Anemia mild to absent Monocytopenia Circulating Hairy Cells may be very rare; fragile, & not in counting zone) Lymphoplasmacytic Lymphoma-WM +/ Lymphocytosis Rouleaux MCP often IgM type +/ Hyperviscosity Bleeding CNS Sx Blindness Hepatosplenomegaly 13

14 Anemia Thrombocytopenia Rouleaux Multiple Myeloma +/- Plasma Cells or Plasmacytoid Lymphs Primary PCL DDx = LPL Plasma Cell Leukemia Secondary PCL - Hx of MM 14

15 Mature T-Cell Neoplasms Cytology T-LGL SS/MF ATLL T-PLL PTCL Patterns of Lymphoid Neoplasia in PB Patterns of Lymphoid Neoplasia Emerge when we correlate ALL available data Detection of these Diseases is Primarily OUR Responsibility Detection in Peripheral Blood > to Detection in Peripheral Blood > to Molecular Diagnosis An Emerging Paradigm 15

16 QUESTIONS?? 16

The spectrum of flow cytometry of the bone marrow

The spectrum of flow cytometry of the bone marrow The spectrum of flow cytometry of the bone marrow Anna Porwit Lund University Faculty of Medicine Dept. of Clinical Sciences Div. Oncology and Pathology anna.porwit@med.lu.se Disclosure of speaker s interests

More information

The patient had a mild splenomegaly but no obvious lymph node enlargement. The consensus phenotype obtained from part one of the exercise was:

The patient had a mild splenomegaly but no obvious lymph node enlargement. The consensus phenotype obtained from part one of the exercise was: Case History An 86 year old male was admitted to hospital with chest infection. Haematological examination subsequently revealed the following: Hb- 11.0 g/dl; WBC- 67.1 x 10^9/l; PLT- 99 x10^9/l; RBC-

More information

Reactive and Neoplastic Lymphocytosis

Reactive and Neoplastic Lymphocytosis Reactive and Neoplastic Lymphocytosis Koranda A. Walsh, VMD, BS Assistant Professor, Clinical Pathobiology University of Pennsylvania School of Veterinary Medicine PLEASE NOTE: These notes are meant as

More information

Flow cytometric analysis of B-cell lymphoproliferative disorders

Flow cytometric analysis of B-cell lymphoproliferative disorders Flow cytometric analysis of B-cell lymphoproliferative disorders David M. Dorfman, M.D., Ph.D. Department of Pathology Brigham and Women s Hospital and Harvard Medical School Boston, MA Objectives Review

More information

7 Omar Abu Reesh. Dr. Ahmad Mansour Dr. Ahmad Mansour

7 Omar Abu Reesh. Dr. Ahmad Mansour Dr. Ahmad Mansour 7 Omar Abu Reesh Dr. Ahmad Mansour Dr. Ahmad Mansour -Leukemia: neoplastic leukocytes circulating in the peripheral bloodstream. -Lymphoma: a neoplastic process in the lymph nodes, spleen or other lymphatic

More information

Lymphoma Tumor Board Quiz! Laboratory Hematology: Basic Cell Morphology

Lymphoma Tumor Board Quiz! Laboratory Hematology: Basic Cell Morphology Lymphoma Tumor Board Quiz! Laboratory Hematology: Basic Cell Morphology CABOT RINGS Cabot rings in a patient with hemolytic anemia. Cabot ring (red arrow) and Howell-Jolly body (blue arrow). Observed in

More information

5000 International Clinical Cytometry Society: Practical Flow Cytometry in Hematopathology A Case-Based Approach

5000 International Clinical Cytometry Society: Practical Flow Cytometry in Hematopathology A Case-Based Approach 5000 International Clinical Cytometry Society: Practical Flow Cytometry in Hematopathology A Case-Based Approach Joseph A DiGiuseppe, MD, PhD Hartford Hospital Disclosures In the past 12 months, I have

More information

LES CAHIERS CERBA. Recommendations for the diagnosis and interpretation of blood lymphocytosis

LES CAHIERS CERBA. Recommendations for the diagnosis and interpretation of blood lymphocytosis LES CAHIERS CERBA Recommendations for the diagnosis and interpretation of blood lymphocytosis written by B. Caron Servan, S. Defasque, C. Hémar, H. Mossafa Clinical pathologists, Laboratoire CERBA LES

More information

Case Report Primary Hairy Cell Leukemia/Lymphoma of the Breast: A Case Report and Review of the Literature

Case Report Primary Hairy Cell Leukemia/Lymphoma of the Breast: A Case Report and Review of the Literature Hindawi Publishing Corporation Volume 2014, Article ID 497027, 5 pages http://dx.doi.org/10.1155/2014/497027 Case Report Primary Hairy Cell Leukemia/Lymphoma of the Breast: A Case Report and Review of

More information

Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure

Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure I am receiving an honorarium from Sysmex for today s presentation. 1 Determining the Etiology for

More information

Pathology of the indolent B-cell lymphomas Elias Campo

Pathology of the indolent B-cell lymphomas Elias Campo Pathology of the indolent B-cell lymphomas Elias Campo Hospital Clinic, University of Barcelona Small B-cell lymphomas Antigen selection NAIVE -B LYMPHOCYTE MEMORY B-CELL MCL FL LPL MZL CLL Small cell

More information

Case 3. Ann T. Moriarty,MD

Case 3. Ann T. Moriarty,MD Case 3 Ann T. Moriarty,MD Case 3 59 year old male with asymptomatic cervical lymphadenopathy. These images are from a fine needle biopsy of a left cervical lymph node. Image 1 Papanicolaou Stained smear,100x.

More information

Leukocytosis - Some Learning Points

Leukocytosis - Some Learning Points Leukocytosis - Some Learning Points Koh Liang Piu Department of Hematology-Oncology National University Cancer Institute National University Health System Objectives of this talk: 1. To provide some useful

More information

Pathology #07. Hussein Al-Sa di. Dr. Sohaib Al-Khatib. Mature B-Cell Neoplasm. 0 P a g e

Pathology #07. Hussein Al-Sa di. Dr. Sohaib Al-Khatib. Mature B-Cell Neoplasm. 0 P a g e Pathology #07 Mature B-Cell Neoplasm Hussein Al-Sa di Dr. Sohaib Al-Khatib 0 P a g e Thursday 18/2/2016 Our lecture today (with the next 2 lectures) will be about lymphoid tumors This is a little bit long

More information

Participants Identification No. % Evaluation

Participants Identification No. % Evaluation BMD-02 Cell Identification Participants Identification No. % Evaluation Erythrocyte precursor, normal 228 95.8 Educational Erythrocyte, normal 7 3.0 Educational Erythrocyte precursor with megaloblastic

More information

HENATOLYMPHOID SYSTEM THIRD YEAR MEDICAL STUDENTS- UNIVERSITY OF JORDAN AHMAD T. MANSOUR, MD. Parts 2 and 3

HENATOLYMPHOID SYSTEM THIRD YEAR MEDICAL STUDENTS- UNIVERSITY OF JORDAN AHMAD T. MANSOUR, MD. Parts 2 and 3 HENATOLYMPHOID SYSTEM THIRD YEAR MEDICAL STUDENTS- UNIVERSITY OF JORDAN AHMAD T. MANSOUR, MD Parts 2 and 3 NEOPLASTIC LYMPHOID DISEASES Introduction o The bone marrow is the source of all cells in the

More information

Session 5. Pre-malignant clonal hematopoietic proliferations. Chairs: Frank Kuo and Valentina Nardi

Session 5. Pre-malignant clonal hematopoietic proliferations. Chairs: Frank Kuo and Valentina Nardi Session 5 Pre-malignant clonal hematopoietic proliferations Chairs: Frank Kuo and Valentina Nardi Pre-malignant clonal hematopoietic proliferations Clonal LYMPHOID proliferations: - Monoclonal gammopathy

More information

LYMPHOMAS an overview of some subtypes of NHLs

LYMPHOMAS an overview of some subtypes of NHLs One of the confusing aspects of the lymphoid neoplasms concerns the use of the descriptive terms "leukemia" and "lymphoma." LYMPHOMAS an overview of some subtypes of NHLs Leukemia is used for lymphoid

More information

WHO Classification. B-cell chronic lymphocytic leukemia/small T-cell granular lymphocytic leukemia

WHO Classification. B-cell chronic lymphocytic leukemia/small T-cell granular lymphocytic leukemia Blood Malignancies-II Prof. Dr. Herman Hariman, a Ph.D, SpPK (KH). Prof. Dr. Adikoesoema Aman, SpPK (KH) Dept. of Clinical Pathology, School of Medicine, University of North Sumatra WHO classification

More information

Immunopathology of Lymphoma

Immunopathology of Lymphoma Immunopathology of Lymphoma Noraidah Masir MBBCh, M.Med (Pathology), D.Phil. Department of Pathology Faculty of Medicine Universiti Kebangsaan Malaysia Lymphoma classification has been challenging to pathologists.

More information

Gray Zones and Double Hits Distinguishing True Burkitt Lymphoma from Other High-Grade B-NHLs Burkitt Lymphoma Burkitt-Like Lymphoma DLBCL Patrick Tres

Gray Zones and Double Hits Distinguishing True Burkitt Lymphoma from Other High-Grade B-NHLs Burkitt Lymphoma Burkitt-Like Lymphoma DLBCL Patrick Tres Gray Zones and Double Hits Distinguishing True Burkitt Lymphoma from Other High-Grade B-NHLs Burkitt Lymphoma Burkitt-Like Lymphoma DLBCL Patrick Treseler, MD, PhD University of California San Francisco

More information

From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology. Songlin Zhang, MD, PhD LSUHSC-Shreveport

From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology. Songlin Zhang, MD, PhD LSUHSC-Shreveport From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology Songlin Zhang, MD, PhD LSUHSC-Shreveport I have no Conflict of Interest. FNA on Lymphoproliferative

More information

Pathology of Hematopoietic and Lymphoid tissue

Pathology of Hematopoietic and Lymphoid tissue CONTENTS Pathology of Hematopoietic and Lymphoid tissue White blood cells and lymph nodes Quantitative disorder of white blood cells Reactive lymphadenopathies Infectious lymphadenitis Tumor metastasis

More information

Differential diagnosis of hematolymphoid tumors composed of medium-sized cells. Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital

Differential diagnosis of hematolymphoid tumors composed of medium-sized cells. Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital Differential diagnosis of hematolymphoid tumors composed of medium-sized cells Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital Lymphoma classification Lymphoma diagnosis starts with morphologic

More information

Efficient assessment of peripheral blood lymphocytosis in adults: developing new thresholds for blood smear review by pathologists

Efficient assessment of peripheral blood lymphocytosis in adults: developing new thresholds for blood smear review by pathologists Clin Chem Lab Med 24; aop Victor Tseng, Adam S. Morgan, Catherine P. Leith and David T. Yang * Efficient assessment of peripheral blood lymphocytosis in adults: developing new thresholds for blood smear

More information

Molecular Advances in Hematopathology

Molecular Advances in Hematopathology Molecular Advances in Hematopathology HOW MOLECULAR METHODS HAVE CHANGED MY PRACTICE Objectives Understand the importance of cytogenetic/molecular studies in hematolymphoid diseases Know some of the important

More information

CD5~ Small B-Cell Leukemias Are Rarely Classifiable as Chronic Lymphocytic Leukemia

CD5~ Small B-Cell Leukemias Are Rarely Classifiable as Chronic Lymphocytic Leukemia Hematopathology / CD5- LYMPHOPROLIFERATIVE DISORDERS CD5~ Small B-Cell Leukemias Are Rarely Classifiable as Chronic Lymphocytic Leukemia Jane C. Huang, M D, William G. Finn, M D, Charles L. Goolsby, PhD,

More information

Small B-cell (Histologically Low Grade) Lymphoma

Small B-cell (Histologically Low Grade) Lymphoma Frequency of Lymphoid Neoplasms Small B-cell (Histologically Low Grade) Lymphoma Stephen Hamilton-Dutoit Institute of Pathology Aarhus University Hospital B-cell neoplasms 88% Diffuse large B-cell lymphoma

More information

Acute Lymphoblastic Leukaemia

Acute Lymphoblastic Leukaemia Acute Lymphoblastic Leukaemia Terri Boyer 17 th October 2006 Overview Disease information: Aetiology of ALL proposed theory, contributing factors Symptoms Complications Diagnostic approaches - morphology

More information

ACCME/Disclosures 4/13/2016. Clinical History

ACCME/Disclosures 4/13/2016. Clinical History ACCME/Disclosures The USCAP requires that anyone in a position to influence or control the content of CME disclose any relevant financial relationship WITH COMMERCIAL INTERESTS which they or their spouse/partner

More information

Hepatic Lymphoma Diagnosis An Algorithmic Approach

Hepatic Lymphoma Diagnosis An Algorithmic Approach Hepatic Lymphoma Diagnosis An Algorithmic Approach Ryan M. Gill, M.D., Ph.D. University of California, San Francisco PLEASE TURN OFF YOUR CELL PHONES Disclosure of Relevant Financial Relationships USCAP

More information

Diagnostic Approach for Eosinophilia and Mastocytosis. Curtis A. Hanson, M.D.

Diagnostic Approach for Eosinophilia and Mastocytosis. Curtis A. Hanson, M.D. Diagnostic Approach for Eosinophilia and Mastocytosis Curtis A. Hanson, M.D. 2014 MFMER slide-1 DISCLOSURES: Relevant Financial Relationship(s) None Off Label Usage None 2014 MFMER slide-2 Molecular Classification

More information

Non-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL)

Non-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL) Non-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL) Lymphoid Neoplasms: 1- non-hodgkin lymphomas (NHLs) 2- Hodgkin lymphoma 3- plasma cell neoplasms Non-Hodgkin lymphomas (NHLs) Acute Lymphoblastic Leukemia/Lymphoma

More information

Methods used to diagnose lymphomas

Methods used to diagnose lymphomas Institut für Pathologie Institut für Pathologie Methods used to diagnose lymphomas Prof. Dr.Med. Leticia Quintanilla-Fend Molecular techniques NGS histology Cytology AS-PCR Sanger seq. MYC Immunohistochemistry

More information

DETERMINATION OF A LYMPHOID PROCESS

DETERMINATION OF A LYMPHOID PROCESS Chapter 2 Applications of Touch Preparation Cytology to Intraoperative Consultations: Lymph Nodes and Extranodal Tissues for Evaluation of Hematolymphoid Disorders INTRODUCTION As discussed in Chap. 1,

More information

PhenoPath. Diagnoses you can count on B CELL NON-HODGKIN LYMPHOMA

PhenoPath. Diagnoses you can count on B CELL NON-HODGKIN LYMPHOMA PhenoPath Diagnoses you can count on B CELL NON-HODGKIN LYMPHOMA C urrent diagnosis of B cell non-hodgkin lymphoma (B-NHL) is based on the 2008 WHO Classification of Tumours of Haematopoietic and Lymphoid

More information

WBCs Disorders. Dr. Nabila Hamdi MD, PhD

WBCs Disorders. Dr. Nabila Hamdi MD, PhD WBCs Disorders Dr. Nabila Hamdi MD, PhD ILOs Compare and contrast ALL, AML, CLL, CML in terms of age distribution, cytogenetics, morphology, immunophenotyping, laboratory diagnosis clinical features and

More information

Chronic Lymphocytic Leukemia Mantle Cell Lymphoma Elias Campo

Chronic Lymphocytic Leukemia Mantle Cell Lymphoma Elias Campo Chronic Lymphocytic Leukemia Mantle Cell Lymphoma Elias Campo Hospital Clinic, University of Barcelona Small B-cell lymphomas NAIVE -B LYMPHOCYTE MEMORY CELL CLL MCL FL MZL Small cell size Low proliferation

More information

Classification of Hematologic Malignancies. Patricia Aoun MD MPH

Classification of Hematologic Malignancies. Patricia Aoun MD MPH Classification of Hematologic Malignancies Patricia Aoun MD MPH Objectives Know the basic principles of the current classification system for hematopoietic and lymphoid malignancies Understand the differences

More information

WBCs Disorders 1. Dr. Nabila Hamdi MD, PhD

WBCs Disorders 1. Dr. Nabila Hamdi MD, PhD WBCs Disorders 1 Dr. Nabila Hamdi MD, PhD ILOs Compare and contrast ALL, AML, CLL, CML in terms of age distribution, cytogenetics, morphology, immunophenotyping, laboratory diagnosis clinical features

More information

Lymphoid Neoplasms. Sylvie Freeman Department of Clinical Immunology, University of Birmingham

Lymphoid Neoplasms. Sylvie Freeman Department of Clinical Immunology, University of Birmingham Lymphoid Neoplasms Sylvie Freeman Department of Clinical Immunology, University of Birmingham Incidence of Haematological Malignancies UK2001 (CRUK) Malignancy New Cases All Cancers 271,000 Leukaemia 6,760

More information

Lymphoma/CLL 101: Know your Subtype. Dr. David Macdonald Hematologist, The Ottawa Hospital

Lymphoma/CLL 101: Know your Subtype. Dr. David Macdonald Hematologist, The Ottawa Hospital Lymphoma/CLL 101: Know your Subtype Dr. David Macdonald Hematologist, The Ottawa Hospital Function of the Lymph System Lymph Node Lymphocytes B-cells develop in the bone marrow and influence the immune

More information

Contents. vii. Preface... Acknowledgments... v xiii

Contents. vii. Preface... Acknowledgments... v xiii Contents Preface... Acknowledgments... v xiii SECTION I 1. Introduction... 3 Knowledge-Based Diagnosis... 4 Systematic Examination of the Lymph Node... 7 Cell Type Identification... 9 Cell Size and Cellularity...

More information

A Practical Guide To Diagnose B-Cell Lymphomas on FNAs. Nancy P. Caraway, M.D.

A Practical Guide To Diagnose B-Cell Lymphomas on FNAs. Nancy P. Caraway, M.D. A Practical Guide To Diagnose B-Cell Lymphomas on FNAs Nancy P. Caraway, M.D. Major Factors Impacting Dx Lymphomas on Small Bxs Classification systems Immunophenotyping by multiprobe flow cytometry and

More information

Lymphoid Neoplasms Associated With IgM Paraprotein A Study of 382 Patients

Lymphoid Neoplasms Associated With IgM Paraprotein A Study of 382 Patients Hematopathology / LYMPHOMAS WITH IGM PARAPROTEIN Lymphoid Neoplasms Associated With IgM Paraprotein A Study of 382 Patients Pei Lin, MD, 1 Suyang Hao, MD, 1* Beverly C. Handy, MD, 2 Carlos E. Bueso-Ramos,

More information

Pathology of Hematopoietic and Lymphoid tissue

Pathology of Hematopoietic and Lymphoid tissue Pathology of Hematopoietic and Lymphoid tissue Peerayut Sitthichaiyakul, M.D. Department of Pathology and Forensic Medicine Faculty of Medicine, Naresuan University CONTENTS White blood cells and lymph

More information

2013 AAIM Pathology Workshop

2013 AAIM Pathology Workshop 2013 AAIM Pathology Workshop John Schmieg, M.D., Ph.D. None Disclosures 1 Pathology Workshop Objectives Define the general philosophy of reviewing pathology reports Review the various components of Bone

More information

Commentary on the WHO Classification of Tumors of Lymphoid Tissues (2008): Indolent B Cell Lymphomas

Commentary on the WHO Classification of Tumors of Lymphoid Tissues (2008): Indolent B Cell Lymphomas Commentary on the WHO Classification of Tumors of Lymphoid Tissues (2008): Indolent B Cell Lymphomas The Harvard community has made this article openly available. Please share how this access benefits

More information

Case Workshop of Society for Hematopathology and European Association for Haematopathology

Case Workshop of Society for Hematopathology and European Association for Haematopathology Case 148 2007 Workshop of Society for Hematopathology and European Association for Haematopathology Robert P Hasserjian Department of Pathology Massachusetts General Hospital Boston, MA Clinical history

More information

Blood Cell Identification Graded

Blood Cell Identification Graded Blood Cell Identification Graded BCK/BCP-11 BCK BCP Referees Participants Participants Performance Identification No. % No. % No. % Evaluation Neutrophil, segmented or band Neutrophil with Pelger-Huët

More information

HEMATOPATHOLOGY (SHANDS HOSPITAL AT THE UNIVERSITY OF FLORIDA): Rotation Director: Ying Li, M.D., Ph.D., Assistant Professor

HEMATOPATHOLOGY (SHANDS HOSPITAL AT THE UNIVERSITY OF FLORIDA): Rotation Director: Ying Li, M.D., Ph.D., Assistant Professor HEMATOPATHOLOGY (SHANDS HOSPITAL AT THE UNIVERSITY OF FLORIDA): Rotation Director: Ying Li, M.D., Ph.D., Assistant Professor I. Description of the rotation: During this rotation, the resident will gain

More information

Malignant or benign leukocytosis

Malignant or benign leukocytosis PEARLS AND PITFALLS IN THE HEMATOLOGY LAB:UPDATES ON CELLULAR DIAGNOSTICS Malignant or benign leukocytosis Tracy I. George 1 1 Department of Pathology, Stanford University School of Medicine, Stanford,

More information

Follicular Lymphoma: the WHO

Follicular Lymphoma: the WHO Follicular Lymphoma: the WHO and the WHERE? Yuri Fedoriw, MD Associate Professor of Pathology and Laboratory Medicine Director of Hematopathology University of North Carolina Chapel Hill, NC Disclosure

More information

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA. April 16, 2008

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA. April 16, 2008 MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA April 16, 2008 FACULTY COPY GOAL: Learn the appearance of normal peripheral blood elements and lymph nodes. Recognize abnormal peripheral blood

More information

Blood Cell Identification: 2011-B Mailing: Acute Myeloid Leukemia (AML)

Blood Cell Identification: 2011-B Mailing: Acute Myeloid Leukemia (AML) Please Note: To view the Figures and Images contained within this education activity in color, access the electronic version of the reading. CASE HISTORY This peripheral blood smear is from a 51-year-old

More information

Case Presentation. Attilio Orazi, MD

Case Presentation. Attilio Orazi, MD Case Presentation Attilio Orazi, MD Weill Cornell Medical College/ NYP Hospital Department of Pathology and Laboratory Medicine New York, NY United States History 60 year old man presented with anemia

More information

88-year-old Female with Lymphadenopathy. Faizi Ali, MD

88-year-old Female with Lymphadenopathy. Faizi Ali, MD 88-year-old Female with Lymphadenopathy Faizi Ali, MD Clinical History A 88-year-old caucasian female presented to our hospital with the complaints of nausea, vomiting,diarrhea, shortness of breath and

More information

Blood Cell Identification Graded

Blood Cell Identification Graded BCP-21 Blood Cell Identification Graded Case History The patient is a 37-year-old female with a history of multiple sickle cell crises. She now presents with avascular necrosis of the left hip. Laboratory

More information

ADx Bone Marrow Report. Patient Information Referring Physician Specimen Information

ADx Bone Marrow Report. Patient Information Referring Physician Specimen Information ADx Bone Marrow Report Patient Information Referring Physician Specimen Information Patient Name: Specimen: Bone Marrow Site: Left iliac Physician: Accession #: ID#: Reported: 08/19/2014 - CHRONIC MYELOGENOUS

More information

Tel: Fax: Received: 25, Jul, 2014 Accepted: 16, Dec, 2014

Tel: Fax: Received: 25, Jul, 2014 Accepted: 16, Dec, 2014 IJHOSCR International Journal of Hematology- Oncology and Stem Cell Research Original Article T-cell/Natural killer-cell neoplasms presenting as leukemia- Case series from single tertiary care center Shano

More information

Outlines. Disclosures. Updates on B-cell Chronic Lymphoproliferative Disorders of the Blood and Bone Marrow

Outlines. Disclosures. Updates on B-cell Chronic Lymphoproliferative Disorders of the Blood and Bone Marrow Updates on B-cell Chronic Lymphoproliferative Disorders of the Blood and Bone Marrow Sa A, Wang MD Jeffrey L. Jorgensen, MD, PhD Department of Hematopathology, UT M.D. Anderson Cancer Center, Houston,

More information

Chronic Lymphocytic Leukemia FISH Panel. Impact on Diagnosis

Chronic Lymphocytic Leukemia FISH Panel. Impact on Diagnosis Hematopathology / CLL, FISH, AND 14Q32 TRANSLOCATIONS Chronic Lymphocytic Leukemia FISH Panel Impact on Diagnosis Beverly P. Nelson, MD, 1 Rohit Gupta, MD, 1 Gordon W. Dewald, PhD, 2 Sarah F. Paternoster,

More information

Clinical question. Screening tube. Diagnostic panel MRD. Clinical question

Clinical question. Screening tube. Diagnostic panel MRD. Clinical question OW CYTOMETRY UPDATES IN LYMPHOPROLIFERATIVE DISORDERS CANCER RESEARCH CENTER IBSAL UNIVERSITY & UNIVERSITY HOSPITAL, SALAMANCA (SPAIN) DISCLOSURES The EuroFlow Scientific Consortium Iamco-chairof receives

More information

Leukocytosis D. S. CHABOT-RICHARDS, T. I. GEORGE SUMMARY INTRODUCTION. International Journal of Laboratory Hematology REVIEW

Leukocytosis D. S. CHABOT-RICHARDS, T. I. GEORGE SUMMARY INTRODUCTION. International Journal of Laboratory Hematology REVIEW International Journal of Laboratory Hematology REVIEW The Official journal of the International Society for Laboratory Hematology INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY Leukocytosis D. S. CHABOT-RICHARDS,

More information

Society for Hematopathology 2017

Society for Hematopathology 2017 Society for Hematopathology 2017 Session 2 Genetic Testing in the Diagnosis of Lymphoid Neoplasms Summary of the cases Session Chairs: Rebecca King and Miguel Piris September 7, 2017 Lymphoma diseases/variants

More information

2010 Hematopoietic and Lymphoid ICD-O Codes - Alphabetical List THIS TABLE REPLACES ALL ICD-O-3 Codes

2010 Hematopoietic and Lymphoid ICD-O Codes - Alphabetical List THIS TABLE REPLACES ALL ICD-O-3 Codes Acute basophilic leukemia 9870/3 Acute biphenotypic leukemia [OBS] 9805/3 Acute erythroid leukemia 9840/3 Acute megakaryoblastic leukemia 9910/3 Acute monoblastic and monocytic leukemia 9891/3 Acute myeloid

More information

2012 Hematopoietic and Lymphoid ICD-O Codes - Numerical List THIS TABLE REPLACES ALL ICD-O-3 Codes

2012 Hematopoietic and Lymphoid ICD-O Codes - Numerical List THIS TABLE REPLACES ALL ICD-O-3 Codes Malignant lymphoma, NOS 9590/3 Non-Hodgkin lymphoma, NOS 9591/3 B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma 9596/3 Primary

More information

Integrated Diagnostic Approach to the Classification of Myeloid Neoplasms. Daniel A. Arber, MD Stanford University

Integrated Diagnostic Approach to the Classification of Myeloid Neoplasms. Daniel A. Arber, MD Stanford University Integrated Diagnostic Approach to the Classification of Myeloid Neoplasms Daniel A. Arber, MD Stanford University What is an integrated approach? What is an integrated approach? Incorporating all diagnostic

More information

Immunophenotyping in the diagnosis of chronic lymphoproliferative disorders

Immunophenotyping in the diagnosis of chronic lymphoproliferative disorders J7 Clin Pathol 1994;47:871-875 871 L eaders~~~~~~~~~~~~~~~~.........;->:>> :*--:-- :- -::-*;:- --::- >:-:;-:: ::;...:::::...::::::::::*::;:;;::;::;::;;:;;:;;::;::;::;;:;;:;:::::::::::::::::: Task Force

More information

Chronic Lymphatic Leukemia Current Management Strategy

Chronic Lymphatic Leukemia Current Management Strategy Chronic Lymphatic Leukemia Current Management Strategy 463 80 Chronic Lymphatic Leukemia Current Management Strategy PK SASIDHARAN CHRONIC LYMPHATIC LEUKEMIA (CLL) CURRENT MANAGEMENT STRATEGY CLL is said

More information

accumulation the blood, marrow, lymph nodes, and spleen.

accumulation the blood, marrow, lymph nodes, and spleen. Chronic Lymphocytic Leukemia accumulation of mature-appearing appearing lymphocytes in the blood, marrow, lymph nodes, and spleen. CLL cells are: monoclonal l B lymphocytes that express CD19. CD5, and

More information

Hematopathology Case Study

Hematopathology Case Study Hematopathology Case Study AMP Outreach Course 2009 AMP Annual Meeting John Greg Howe Ph.D. Department of Laboratory Medicine Yale University School of Medicine November 19, 2009 HISTORY Case History An

More information

Blood Cell Morphology. Pr François MULLIER, Pr Bernard CHATELAIN BHS course, October 12th, 2013

Blood Cell Morphology. Pr François MULLIER, Pr Bernard CHATELAIN BHS course, October 12th, 2013 Blood Cell Morphology Pr François MULLIER, Pr Bernard CHATELAIN BHS course, October 12th, 2013 Blood cell morphology Validation of the hematology counter parameters (PLT count, MCV ) Lack of sensitivity

More information

2007 Workshop of Society for Hematopathology & European Association for Hematopathology Indianapolis, IN, USA Case # 228

2007 Workshop of Society for Hematopathology & European Association for Hematopathology Indianapolis, IN, USA Case # 228 2007 Workshop of Society for Hematopathology & European Association for Hematopathology Indianapolis, IN, USA Case # 228 Vishnu V. B Reddy, MD University of Alabama at Birmingham Birmingham, AL USA 11/03/07

More information

B-cell Chronic Lymphoproliferative Disorders of the Blood and Bone Marrow

B-cell Chronic Lymphoproliferative Disorders of the Blood and Bone Marrow B-cell Chronic Lymphoproliferative Disorders of the Blood and Bone Marrow Sanam Loghavi, MD Department of Hematopathology University of Texas MD Anderson Cancer Center Houston, TX Disclosures I have no

More information

Low-grade B-cell lymphoma

Low-grade B-cell lymphoma Low-grade B-cell lymphoma Patho-Basic 11. September 2018 Stephan Dirnhofer Pathology Outline Definition LPL, MBL/CLL/SLL, MCL FL Subtypes & variants Diagnosis including Grading Transformation Summary Be

More information

Case Presentation No. 075

Case Presentation No. 075 Case Presentation No. 075 Session 4. Myelodysplastic Syndrome Cristina Montalvo, MD Baylor College of Medicine Houston, Texas 2007 Workshop of Society for Hematopathology and European Association for Haematopathology

More information

Hematology Page 1 of 8

Hematology Page 1 of 8 Hematology Page 1 of 8 Hematology Major Category Code Headings Revised 12/17 1 Basic methodology and test armamentarium 20000 2 Normal hematopoiesis & hemostasis 20100 3 RBC disorders, non-neoplastic 20340

More information

Hematology 101. Rachid Baz, M.D. 5/16/2014

Hematology 101. Rachid Baz, M.D. 5/16/2014 Hematology 101 Rachid Baz, M.D. 5/16/2014 Florida 101 Epidemiology Estimated prevalence 8,000 individuals in U.S (compare with 80,000 MM patients) Annual age adjusted incidence 3-8/million-year 1 More

More information

9/28/2017. Follicular Lymphoma and Nodal Marginal Zone Lymphoma. Follicular Lymphoma Definition. Low-Grade B-Cell Lymphomas in WHO Classification

9/28/2017. Follicular Lymphoma and Nodal Marginal Zone Lymphoma. Follicular Lymphoma Definition. Low-Grade B-Cell Lymphomas in WHO Classification and L. Jeffrey Medeiros, MD DISCLOSURES I do not have anything to disclose Low-Grade B-Cell Lymphomas in WHO Classification Lymphoma Type Frequency Follicular lymphoma 22.1 % Extranodal MALT-lymphoma 7.6

More information

HENATOLYMPHOID SYSTEM THIRD YEAR MEDICAL STUDENTS- UNIVERSITY OF JORDAN AHMAD T. MANSOUR, MD. Part 4 MYELOID NEOPLASMS

HENATOLYMPHOID SYSTEM THIRD YEAR MEDICAL STUDENTS- UNIVERSITY OF JORDAN AHMAD T. MANSOUR, MD. Part 4 MYELOID NEOPLASMS HENATOLYMPHOID SYSTEM THIRD YEAR MEDICAL STUDENTS- UNIVERSITY OF JORDAN AHMAD T. MANSOUR, MD Part 4 MYELOID NEOPLASMS Introduction: o Myeloid neoplasms are divided into three major categories: o Acute

More information

Easy Trick to Spot Leukemia for Pediatricians

Easy Trick to Spot Leukemia for Pediatricians Easy Trick to Spot Leukemia for Pediatricians Piya Rujkijyanont, MD Division of Hematology-Oncology Department of Pediatrics Phramongkutklao Hospital Most Common Pediatric Cancers Age 0-14 Leukemia 32%

More information

COMPANY OR UNIVERSITY

COMPANY OR UNIVERSITY CONTRIBUTOR NAME Daniel Heinrich, DVM CONTRIBUTOR EMAIL dheinric@umn.edu COAUTHORS Jed Overmann, DVM, DACVP; Davis Seelig DVM, PhD, DACVP & Matthew Sturos, DVM COMPANY OR UNIVERSITY University of Minnesota

More information

Investigation and Management of Chronic Lymphocytic Leukemia. James Johnston

Investigation and Management of Chronic Lymphocytic Leukemia. James Johnston Investigation and Management of Chronic Lymphocytic Leukemia James Johnston Site Specific Clinics CLL Clinic (787-4454) Erin Elphee BN James Johnston Rajat Kumar Matt Seftel (transplant) Myeloma Clinic

More information

Pathology. #11 Acute Leukemias. Farah Banyhany. Dr. Sohaib Al- Khatib 23/2/16

Pathology. #11 Acute Leukemias. Farah Banyhany. Dr. Sohaib Al- Khatib 23/2/16 35 Pathology #11 Acute Leukemias Farah Banyhany Dr. Sohaib Al- Khatib 23/2/16 1 Salam First of all, this tafreegh is NOT as long as you may think. If you just focus while studying this, everything will

More information

Group of malignant disorders of the hematopoietic tissues characteristically associated with increased numbers of white cells in the bone marrow and

Group of malignant disorders of the hematopoietic tissues characteristically associated with increased numbers of white cells in the bone marrow and Group of malignant disorders of the hematopoietic tissues characteristically associated with increased numbers of white cells in the bone marrow and / or peripheral blood Classified based on cell type

More information

Proper Slide Preparation

Proper Slide Preparation Hematology Essentials: A Foundation for WBC Review Using Case Studies Christine Hinz, MS, MLS(ASCP) CM Proper Slide Preparation smooth, homogenous film 1/2 to 3/4 the slide length straight feather edge

More information

Bone Marrow Involvement in Malignant Lymphomas (Non-Hodgkin ' s) Eman Sadiq Jalal MSc

Bone Marrow Involvement in Malignant Lymphomas (Non-Hodgkin ' s) Eman Sadiq Jalal MSc MSc Abstract: Background: Bone marrow biopsies are taken routinely in the initial investigation of patients with non-hodgkin, s lymphomas to estimate the progression of disease at time of presentation

More information

FLOW CYTOMETRY PRINCIPLES AND PRACTICE. Toby Eyre Consultant Haematologist Oxford University Hospitals NHS Foundation Trust June 2018

FLOW CYTOMETRY PRINCIPLES AND PRACTICE. Toby Eyre Consultant Haematologist Oxford University Hospitals NHS Foundation Trust June 2018 FLOW CYTOMETRY PRINCIPLES AND PRACTICE Toby Eyre Consultant Haematologist Oxford University Hospitals NHS Foundation Trust June 2018 Aims and Objectives Principles of flow cytometry Preparation Steps involved

More information

CHAPTER:4 LEUKEMIA. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY 8/12/2009

CHAPTER:4 LEUKEMIA. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY 8/12/2009 LEUKEMIA CHAPTER:4 1 BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Leukemia A group of malignant disorders affecting the blood and blood-forming tissues of

More information

Diagnosis of lymphoid neoplasms has been

Diagnosis of lymphoid neoplasms has been Iranian Journal of Pathology (2007)2 (1), 1-61 Review Article Mehdi Nassiri Dep. of Pathology, University of Miami Miller School of Medicine, Miami, USA Abstract Correct diagnosis and classification of

More information

Interpreting Hematology Scatter-Plots; One Cancer Center s Keys to Seeing the BIG Picture

Interpreting Hematology Scatter-Plots; One Cancer Center s Keys to Seeing the BIG Picture Interpreting Hematology Scatter-Plots; One Cancer Center s Keys to Seeing the BIG Picture Barbara L. Burch, MHA MT (ASCP) Laboratory Manager New York University Clinical Cancer Center Disclosure Ms Burch

More information

Combinations of morphology codes of haematological malignancies (HM) referring to the same tumour or to a potential transformation

Combinations of morphology codes of haematological malignancies (HM) referring to the same tumour or to a potential transformation Major subgroups according to the World Health Organisation (WHO) Classification Myeloproliferative neoplasms (MPN) Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or

More information

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization Table of Contents: PART I: Molecular and Cellular Basis of Hematology 1 Anatomy and Pathophysiology of the Gene 2 Genomic Approaches to Hematology 3 Regulation of Gene Expression, Transcription, Splicing,

More information

Proceeding of the LAVC Latin American Veterinary Conference Oct , 2009 Lima, Peru

Proceeding of the LAVC Latin American Veterinary Conference Oct , 2009 Lima, Peru Close this window to return to IVIS www.ivis.org Proceeding of the LAVC Latin American Veterinary Conference Oct. 16-19, 2009 Lima, Peru Reprinted in the IVIS website with the permission of the LAVC http://www.ivis.org/

More information

Hematopathology Lab. Third year medical students

Hematopathology Lab. Third year medical students Hematopathology Lab Third year medical students Objectives Identify the lesion Know the specific name of the lesion Know associated disease Know relevant pathologic background Spherocytes: appear small,

More information

Clinical Policy: Bendamustine (Bendeka, Treanda) Reference Number: PA.CP.PHAR.307

Clinical Policy: Bendamustine (Bendeka, Treanda) Reference Number: PA.CP.PHAR.307 Clinical Policy: (Bendeka, Treanda) Reference Number: PA.CP.PHAR.307 Effective Date: 01/18 Last Review Date: 11/17 Coding Implications Revision Log Description The intent of the criteria is to ensure that

More information

Lymph node cytopathology : A practical approach to lymphoproliferative disorders

Lymph node cytopathology : A practical approach to lymphoproliferative disorders Lymph node cytopathology : A practical approach to lymphoproliferative disorders Koray Ceyhan, M.D Department of Pathology Faculty of Medicine Ankara University Ankara, Turkey Diagnostic use of FNA in

More information